IGI Submits IND Application for Multispecific Cancer Candidate ISB 2301 MM Desk 23 November, 2026 Ichnos Glenmark Innovation, Inc (IGI), a clinical-stage biotechnology company developing multispecific therapies for cancer, has Read More